 | • レポートコード：MRC2303F0072 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、226ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に1,913.38百万ドルであった世界のタンパク質標識市場規模が、2022年に2,110.34百万ドルになり、2027年まで年平均10.47%で成長して3,477.72百万ドルに拡大すると予測しています。本レポートは、タンパク質標識の世界市場について調べ、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（キット、試薬、サービス）分析、標識方法別（バイオ直交標識、In Vitro標識、In Vivo標識）分析、用途別（セルベースアッセイ、蛍光顕微鏡、免疫学的技術、マススペクトロメトリー、タンパク質マイクロアレイ）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などを以下の構成でまとめております。また、Active Motif, Inc.、Agilent Technologies Inc.、Bio-Rad Laboratories, Inc.、Biotium, Inc.、Candor Bioscience GmbH、Caprion Biosciences Inc. by GHO Capital Partners LLP、Eurogentec S.A.、F. Hoffmann-La Roche AG、General Electric Company、Innova Biosciences Ltd. by SYGNIS AG、Jena Bioscience GmbH、Kaneka Corporationなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のタンパク質標識市場規模：製品別 - キットの市場規模 - 試薬の市場規模 - サービスの市場規模 ・世界のタンパク質標識市場規模：標識方法別 - バイオ直交標識における市場規模 - In Vitro標識における市場規模 - In Vivo標識における市場規模 ・世界のタンパク質標識市場規模：用途別 - セルベースアッセイにおける市場規模 - 蛍光顕微鏡における市場規模 - 免疫学的技術における市場規模 - マススペクトロメトリーにおける市場規模 - タンパク質マイクロアレイにおける市場規模 ・世界のタンパク質標識市場規模：地域別 - 南北アメリカのタンパク質標識市場規模 アメリカのタンパク質標識市場規模 カナダのタンパク質標識市場規模 ブラジルのタンパク質標識市場規模 … - アジア太平洋のタンパク質標識市場規模 日本のタンパク質標識市場規模 中国のタンパク質標識市場規模 インドのタンパク質標識市場規模 韓国のタンパク質標識市場規模 台湾のタンパク質標識市場規模 … - ヨーロッパ/中東/アフリカのタンパク質標識市場規模 イギリスのタンパク質標識市場規模 ドイツのタンパク質標識市場規模 フランスのタンパク質標識市場規模 ロシアのタンパク質標識市場規模 … - その他地域のタンパク質標識市場規模 ・競争状況 ・企業情報 |
The Global Protein Labeling Market size was estimated at USD 1,913.38 million in 2021 and expected to reach USD 2,110.34 million in 2022, and is projected to grow at a CAGR 10.47% to reach USD 3,477.72 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Protein Labeling to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Kits, Reagents, and Services. The Reagents is further studied across Enzymes, Monoclonal Antibodies, Probes/Tags, and Protein.
Based on Labeling Method, the market was studied across Bioorthogonal Labeling, In Vitro Labeling Methods, and In Vivo Labeling Methods. The In Vitro Labeling Methods is further studied across Cotranslational Labeling, Dye-based, Enzymatic Labeling, Nanoparticle Labeling, and Site-specific Labeling. The In Vivo Labeling Methods is further studied across Photoreactive Labeling and Radioactive Labeling.
Based on Application, the market was studied across Cell-based Assays, Fluorescence Microscopy, Immunological Techniques, Mass Spectrometry, and Protein Microarray.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Protein Labeling market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Protein Labeling Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Protein Labeling Market, including Active Motif, Inc., Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Biotium, Inc., Candor Bioscience GmbH, Caprion Biosciences Inc. by GHO Capital Partners LLP, Eurogentec S.A., F. Hoffmann-La Roche AG, General Electric Company, Innova Biosciences Ltd. by SYGNIS AG, Jena Bioscience GmbH, Kaneka Corporation, LI-COR, Inc., Luminex Corporation, Merck KGaA, NanoTemper Technologies GmbH, New England Biolabs, New England Biolabs, Inc., Perkin Elmer, Inc., Promega Corporation, Seracare Life Sciences, Inc., SeraCare Life Sciences, Inc. by LGC, Takara Bio Inc., and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Protein Labeling Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Protein Labeling Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Protein Labeling Market?
4. What is the competitive strategic window for opportunities in the Global Protein Labeling Market?
5. What are the technology trends and regulatory frameworks in the Global Protein Labeling Market?
6. What is the market share of the leading vendors in the Global Protein Labeling Market?
7. What modes and strategic moves are considered suitable for entering the Global Protein Labeling Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising healthcare expenditure
5.1.1.2. Increasing R&D spending for proteomics research field
5.1.2. Restraints
5.1.2.1. Low availability of skilled professionals
5.1.2.2. High cost and wastage associated with the protein labeling process
5.1.3. Opportunities
5.1.3.1. Increasing adoption of modern molecular biology and bioengineering tools
5.1.3.2. Introduction of new and improved products
5.1.4. Challenges
5.1.4.1. Issues related to fluorescent labeling and modification of proteins
5.2. Cumulative Impact of COVID-19
6. Protein Labeling Market, by Product
6.1. Introduction
6.2. Kits
6.3. Reagents
6.4.1. Enzymes
6.4.2. Monoclonal Antibodies
6.4.3. Probes/Tags
6.4.4. Protein
6.4. Services
7. Protein Labeling Market, by Labeling Method
7.1. Introduction
7.2. Bioorthogonal Labeling
7.3. In Vitro Labeling Methods
7.4.1. Cotranslational Labeling
7.4.2. Dye-based
7.4.3. Enzymatic Labeling
7.4.4. Nanoparticle Labeling
7.4.5. Site-specific Labeling
7.4. In Vivo Labeling Methods
7.5.1. Photoreactive Labeling
7.5.2. Radioactive Labeling
8. Protein Labeling Market, by Application
8.1. Introduction
8.2. Cell-based Assays
8.3. Fluorescence Microscopy
8.4. Immunological Techniques
8.5. Mass Spectrometry
8.6. Protein Microarray
9. Americas Protein Labeling Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Protein Labeling Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Protein Labeling Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Active Motif, Inc.
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Agilent Technologies Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Bio-Rad Laboratories, Inc.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Biotium, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Candor Bioscience GmbH
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Caprion Biosciences Inc. by GHO Capital Partners LLP
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Eurogentec S.A.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. F. Hoffmann-La Roche AG
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. General Electric Company
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Innova Biosciences Ltd. by SYGNIS AG
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Jena Bioscience GmbH
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Kaneka Corporation
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. LI-COR, Inc.
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Luminex Corporation
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Merck KGaA
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. NanoTemper Technologies GmbH
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. New England Biolabs
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. New England Biolabs, Inc.
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Perkin Elmer, Inc.
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Promega Corporation
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Seracare Life Sciences, Inc.
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. SeraCare Life Sciences, Inc. by LGC
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Takara Bio Inc.
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Thermo Fisher Scientific, Inc.
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing